Clinical nutrition as part of the treatment pathway of pancreatic cancer patients: an expert consensus
Author
Date
2022-01Permanent link
https://hdl.handle.net/11351/7805DOI
10.1007/s12094-021-02674-x
ISSN
1699-3055
PMID
34363594
Abstract
Purpose
Malnutrition is a common problem among pancreatic cancer (PC) patients that negatively impacts on their quality of life (QoL) and clinical outcomes. The main objective of this consensus is to address the role of Medical Nutrition Therapy (MNT) into the comprehensive therapeutic management of PC patients.
Methods
A Spanish multidisciplinary group of specialists from the areas of Medical Oncology; Radiation Oncology; Endocrinology and Nutrition; and General Surgery agreed to assess the role of MNT as part of the best therapeutic management of PC patients.
Results
The panel established different recommendations focused on nutritional screening and nutritional screening tools, MNT strategies according to PC status, and MNT in palliative treatment.
Conclusions
There is an unmet need to integrate nutritional therapy as a crucial part of the multimodal care process in PC patients. Health authorities, health care professionals, cancer patients, and their families should be aware of the relevance of nutritional status and MNT on clinical outcomes and QoL of PC patients.
Keywords
Consensus; Nutritional screening; Pancreatic cancerBibliographic citation
Carrato A, Cerezo L, Feliu J, Macarulla T, Martín-Pérez E, Vera R, et al. Clinical nutrition as part of the treatment pathway of pancreatic cancer patients: an expert consensus. Clin Transl Oncol. 2022 Jan;24:112–26.
Audience
Professionals
This item appears in following collections
- HVH - Articles científics [4476]
- VHIO - Articles científics [1250]
The following license files are associated with this item:





